Genetic variations using whole-exome sequencing might predict response for neoadjuvant chemoradiotherapy in locally advanced rectal cancer

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Medical Oncology

• Publication date

  2018-09-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12032-018-1202-8PMID 30206710
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PSMB8 as a Candidate Marker of Responsiveness to Preoperative Radiation Therapy in Rectal Cancer Patients.

  2017cited by this paper
• Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer

  2017cited by this paper
• Next-Generation Sequencing of Matched Primary and Metastatic Rectal Adenocarcinomas Demonstrates Minimal Mutation Gain and Concordance to Colonic Adenocarcinomas.

  2016cited by this paper
• Predictive role of microRNA-related genetic polymorphisms in the pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients

  2016cited by this paper
• Significance of genetic variants in DLC1 and their association with hepatocellular carcinoma

  2015cited by this paper
• Next generation sequencing of triple negative breast cancer to find predictors for chemotherapy response

  2015cited by this paper
• New Perspectives on Predictive Biomarkers of Tumor Response and Their Clinical Application in Preoperative Chemoradiation Therapy for Rectal Cancer

  2015cited by this paper
• MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer

  2015cited by this paper
• Molecular characterization of patients with pathologic complete response or early failure after neoadjuvant chemotherapy for locally advanced breast cancer using next generation sequencing and nCounter assay

  2015cited by this paper
• Sambamba: fast processing of NGS alignment formats

  2015cited by this paper
• Biomarkers and Molecular Imaging as Predictors of Response to Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.

  2015cited by this paper
• Epigenetic inactivation of the novel candidate tumor suppressor gene ITIH5 in colon cancer predicts unfavorable overall survival in the CpG island methylator phenotype

  2014cited by this paper
• Epigenetic inactivation of ITIH5 promotes bladder cancer progression and predicts early relapse of pT1 high-grade urothelial tumours.

  2014cited by this paper
• Novel single-nucleotide polymorphism markers predictive of pathologic response to preoperative chemoradiation therapy in rectal cancer patients.

  2013cited by this paper
• Neoadjuvant treatment response as an early response indicator for patients with rectal cancer.

  2012cited by this paper
• The genotype of RAET1L (ULBP6), a ligand for human NKG2D (KLRK1), markedly influences the clinical outcome of allogeneic stem cell transplantation

  2012cited by this paper
• Downregulation of DLC-1 Gene by Promoter Methylation during Primary Colorectal Cancer Progression

  2012cited by this paper
• Integrative Genomics Viewer

  2011cited by this paper
• Clinical Significance of Pre- to Post-Chemoradiotherapy s-CEA Reduction Ratio in Rectal Cancer Patients Treated with Preoperative Chemoradiotherapy and Curative Resection

  2011cited by this paper
• ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data

  2010cited by this paper
• Identification of genes related to a synergistic effect of taxane and suberoylanilide hydroxamic acid combination treatment in gastric cancer cells

  2010cited by this paper
• Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data.

  2010cited by this paper
• BCL2L10 is frequently silenced by promoter hypermethylation in gastric cancer.

  2010cited by this paper
• ULBP6/RAET1L is an additional human NKG2D ligand

  2009cited by this paper
• The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation

  2008cited by this paper
• Next-generation DNA sequencing

  2008cited by this paper
• SMAD proteins control DROSHA-mediated microRNA maturation

  2008cited by this paper
• Expression profile of the tumor suppressor genes DLC-1 and DLC-2 in solid tumors.

  2006cited by this paper
• Identification of predicted human outer dynein arm genes: candidates for primary ciliary dyskinesia genes

  2005cited by this paper
• Inhibitory Effect of a Conjugate between Human Urokinase and Urinary Trypsin Inhibitor on Tumor Cell Invasion in Vitro(*)

  1995cited by this paper
• BIOINFORMATICS ORIGINAL PAPER

  year unknowncited by this paper

• Genetic Determinants of Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer Identified by Whole Exome Sequencing

  2025cites this paper
• Response prediction for neoadjuvant treatment in locally advanced rectal cancer patients-improvement in decision-making: A systematic review.

  2024cites this paper
• An Overview on the Emerging Role of the Plasma Protease Inhibitor Protein ITIH5 as a Metastasis Suppressor

  2024cites this paper
• Genomic landscape of locally advanced rectal adenocarcinoma: Comparison between before and after neoadjuvant chemoradiation and effects of genetic biomarkers on clinical outcomes and tumor response

  2023cites this paper
• Bcl-B: an “unknown” protein of the Bcl-2 family

  2023cites this paper
• Nrh L11R single nucleotide polymorphism, a new prediction biomarker in breast cancer, impacts endoplasmic reticulum-dependent Ca2+ traffic and response to neoadjuvant chemotherapy

  2023cites this paper
• Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer

  2022cites this paper
• Exome sequencing of glioblastoma-derived cancer stem cells reveals rare clinically relevant frameshift deletion in MLLT1 gene

  2022cites this paper
• Bcl-2-like protein-10 increases aggressive features of melanoma cells

  2022cites this paper
• Nucleic acid-based markers of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.

  2022cites this paper
• A genotype signature for predicting pathologic complete response in locally advanced rectal cancer.

  2021cites this paper
• Exome sequencing of glioblastoma-derived cancer stem cells reveals rare clinically relevant frameshift deletion in MLLT1 gene

  2021cites this paper
• In vitro testicular organogenesis from human fetal gonads produces fertilization-competent spermatids

  2020cites this paper
• BMI May Be a Prognostic Factor for Local Advanced Rectal Cancer Patients Treated with Long-Term Neoadjuvant Chemoradiotherapy

  2020cites this paper
• Germline and Somatic Pharmacogenomics to Refine Rectal Cancer Patients Selection for Neo-Adjuvant Chemoradiotherapy

  2020cites this paper
• OTT_A_256696 6721..6733

  2020cites this paper
• CMAR_A_268928 10321..10332

  2020cites this paper
• A Four Gene-Based Risk Score System Associated with Chemoradiotherapy Response and Tumor Recurrence in Rectal Cancer by Co-Expression Network Analysis

  2020cites this paper
• World Journal of Gastrointestinal Oncology

  year unknowncites this paper